文献速递肺栓塞与肺血管病

骨形态发生蛋白3在肺动脉高压中的旁分泌作用

Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension.
PubMed 文献 · Eur Respir J · 2026-07-30

该研究探讨BMP3在肺动脉高压(PAH)中的作用。BMP3在PAH中表达下调,其缺失加重实验性PAH,而补充BMP3可预防和逆转PAH,机制涉及恢复BMP/SMAD与TGF-β/SMAD信号平衡。

要点

  • BMP3在PAH中表达下调,补充BMP3可逆转肺动脉重塑。
  • BMP3通过旁分泌抑制病变内皮细胞迁移和增殖。
  • BMP3恢复BMP/SMAD与TGF-β/SMAD信号平衡。

核心结论

  • BMP3是肺血管稳态的旁分泌调节因子,可能通过调节TGF-β/BMP信号参与PAH,是潜在治疗靶点。

研究设计与样本

  • 实验性PH模型和PAH患者肺血管细胞及血浆检测BMP3表达。
  • 体外研究使用hPASMCs和hPAECs。
  • 构建全局和SMC特异性Bmp3缺陷小鼠。
  • 使用重组BMP3和AAV过表达BMP3在PAH动物模型中验证。

主要发现

  • BMP3主要表达于PASMCs,在实验性和人类PAH中持续下调。
  • PAH-PASMCs分泌的BMP3和PAH患者循环BMP3水平显著降低。
  • PASMC来源的BMP3抑制PAH病变PAEC的迁移和增殖。
  • 全局和SMC特异性Bmp3缺陷小鼠诱导PAH后,中年小鼠疾病显著加重。
  • 重组BMP3预防和逆转小鼠PAH;AAV1-BMP3肺靶向过表达逆转小鼠和大鼠肺血管重塑并改善心脏功能。

关键数值与推荐

  • BMP3恢复BMP/SMAD1,5,8与TGF-β/SMAD2,3信号平衡,并降低PAECs细胞周期基因表达。

临床怎么用

  • BMP3可能作为PAH治疗靶点,但需进一步临床研究验证。

局限性

  • 研究主要基于动物模型和体外实验,人类数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in therapy, pulmonary arterial hypertension (PAH) remains progressive with poor survival. Although dysregulation of Bone Morphogenetic Protein (BMP) signaling is central to PAH, key modulators of this pathway remain incompletely defined. OBJECTIVES: To identify the role of BMP3 in pulmonary vascular homeostasis and PAH. METHODS: BMP3 expression was assessed in experimental pulmonary hypertension (PH) and in pulmonary vascular cells and plasma from PAH patients. In vitro studies were performed in human pulmonary artery smooth muscle cells (hPASMCs) and endothelial cells (hPAECs). Global and SMC-specific Bmp3-deficient mice were generated. Recombinant BMP3 and adeno-associated viruses (AAV) were used to overexpress BMP3 in animal models of PAH. RESULTS: BMP3 is predominantly expressed in PASMCs and is consistently downregulated in experimental and human PAH. Secreted BMP3 from PAH-PASMCs and circulating BMP3 levels in PAH patients were significantly reduced. Functionally, PASMC-derived BMP3 inhibited the migration and proliferation of PAH-diseased PAEC. In both global and SMC-specific Bmp3-deficient mice, induction of PAH led to significantly exacerbated disease in middle-aged mice. A recombinant BMP3 prevented and reversed PAH in mice. Furthermore, lung-targeted overexpression of BMP3, via AAV1-BMP3, reversed pulmonary vascular remodeling and ameliorated cardiac function in both mice and rats. Mechanistically, BMP3 restored the balance between BMP/SMAD1,5,8 and TGF-β/SMAD2,3 signaling, and decreased the expression of cell cycle genes in PAECs. CONCLUSIONS: BMP3 acts as a paracrine regulator of pulmonary vascular homeostasis and may contribute to the modulation of TGF-β/BMP signaling in PAH, highlighting its potential as a therapeutic target.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Halouani A, Mensah E, Ben Rhouma M, et al. Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension. Eur Respir J. 2026. PMID: 42532545. doi:10.1183/13993003.02146-2025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。